Lahoz C - Search Results

1

[Atherosclerosis as a systemic disease].

Lahoz C, Mostaza JM. Lahoz C, et al. Rev Esp Cardiol. 2007 Feb;60(2):184-95. Rev Esp Cardiol. 2007. PMID: 17338883 Free article. Spanish.

2

Utilization of evidence-based cardiovascular therapies and achievement of therapeutic goals in patients with peripheral artery disease.

Mostaza JM, Puras E, Blasco M, Lahoz C, Samaniego ML. Mostaza JM, et al. Among authors: lahoz c. Rev Esp Cardiol (Engl Ed). 2012 Aug;65(8):713-8. doi: 10.1016/j.recesp.2012.02.020. Epub 2012 May 31. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22658690 English, Spanish.

3

Peripheral Atherosclerosis in Patients With Erectile Dysfunction: A Population-Based Study.

Lahoz C, Mostaza JM, Salinero-Fort MA, García-Iglesias F, González-Alegre T, Estirado E, Laguna F, de Burgos-Lunar C, Sánchez-Arroyo V, Sabín C, López S, Cornejo-Del-Río V, Patrón P, Fernández-García P, Fernández-Puntero B, Vicent D, Montesano-Sanchez L; SPREDIA-2 Group. Lahoz C, et al. J Sex Med. 2016 Jan;13(1):63-9. doi: 10.1016/j.jsxm.2015.11.011. J Sex Med. 2016. PMID: 26755088

4

Atherogenic dyslipidemia in patients with established coronary artery disease.

Lahoz C, Mostaza JM, Tranche S, Martin-Jadraque R, Mantilla MT, López-Rodriguez I, Monteiro B, Sanchez-Zamorano MA, Taboada M. Lahoz C, et al. Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):103-8. doi: 10.1016/j.numecd.2010.04.010. Epub 2010 Aug 2. Nutr Metab Cardiovasc Dis. 2012. PMID: 20675108

5

[Prevalence of metabolic syndrome in patients with stable coronary disease: therapeutic objectives and utilization of cardiovascular drugs].

Lahoz C, Mostaza JM, Mantilla MT, Taboada M, Tranche S, López-Rodríguez I, Monteiro B, Sánchez-Zamorano MA, Martín-Jadraque R. Lahoz C, et al. Rev Clin Esp. 2011 Jan;211(1):1-8. doi: 10.1016/j.rce.2010.05.018. Epub 2010 Dec 31. Rev Clin Esp. 2011. PMID: 21196002 Spanish.

6

Cardiovascular morbidity-mortality associated to ankle-brachial index in the general population.

Lahoz C, Barrionuevo M, García-Fernández T, Vicente I, García-Iglesias MF, Mostaza JM. Lahoz C, et al. Rev Clin Esp (Barc). 2014 Jan-Feb;214(1):1-7. doi: 10.1016/j.rce.2013.08.008. Epub 2013 Oct 9. Rev Clin Esp (Barc). 2014. PMID: 24119392 English, Spanish.

7

Metabolic syndrome in patients with peripheral arterial disease.

Estirado E, Lahoz C, Laguna F, García-Iglesias F, González-Alegre MT, Mostaza JM. Estirado E, et al. Among authors: lahoz c. Rev Clin Esp (Barc). 2014 Nov;214(8):437-44. doi: 10.1016/j.rce.2014.05.005. Epub 2014 Jun 21. Rev Clin Esp (Barc). 2014. PMID: 24958317 English, Spanish.

8

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.

Lahoz C, Peña R, Mostaza JM, Jiménez J, Subirats E, Pintó X, Taboada M, López-Pastor A; RAP Study Group. Lahoz C, et al. Atherosclerosis. 2003 Jun;168(2):289-95. doi: 10.1016/s0021-9150(03)00094-7. Atherosclerosis. 2003. PMID: 12801612

9

[Ankle brachial index and cardiovascular risk].

Mostaza JM, Vicente I, Cairols M, Castillo J, González-Juanatey JR, Pomar JL, Lahoz C. Mostaza JM, et al. Among authors: lahoz c. Med Clin (Barc). 2003 Jun 14;121(2):68-73. doi: 10.1016/s0025-7753(03)73857-3. Med Clin (Barc). 2003. PMID: 12828888 Review. Spanish. No abstract available.

10

C-reactive protein levels and prevalence of chronic infections in subjects with hypoalphalipoproteinemia.

Mostaza JM, Camino N, Gerique JG, Peña R, Baquero M, Lahoz C. Mostaza JM, et al. Among authors: lahoz c. Metabolism. 2005 Jan;54(1):33-7. doi: 10.1016/j.metabol.2004.07.009. Metabolism. 2005. PMID: 15562377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters